Kimia Biosciences
↗New Delhi, India
Kimia Biosciences Limited is a leading Indian pharmaceutical company specializing in the manufacture of Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), and intermediates. Formerly known as Laurel Organics Limited, the company has transitioned into a research-driven organization focusing on high-potential therapeutic segments such as lifestyle diseases, gastrointestinal agents, and anti-diabetics.
The company operates a state-of-the-art manufacturing facility in Gurugram, Haryana, which is WHO-GMP approved. Kimia is recognized for its 'first-to-India' product launches and its robust R&D capabilities, supported by a team of over 80 scientists. It provides both generic API supply and Contract Development and Manufacturing Organization (CDMO) services to global pharmaceutical partners.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Revenue:$10M-$50M
Founded:1993
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:Public Shareholders, Sameer Goel (Promoter)
STOCK
Exchange:BSE
Ticker:530313
Market Cap:$16.6M
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Strategic CDMO partnerships with global generic firms
COMPETITION
Position:Niche Player
Competitors:Laurus Labs, Aarti Drugs, Divi's Laboratories, Granules India
LEADERSHIP
Key Executives:
Sameer Goel - Chairman & Managing Director
Vijayasekhar Reddy Kaku - COO
Scientific Founders:Sameer Goel
Board Members:Sameer Goel, Jagdeep Dhawan, Richa Gupta, Vipul Goel
LINKS
Website:kimiabiosciences.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Kimia Biosciences. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.